Tetsuya Hosaka

12.5k citations

324 papers · 9.0k · 2 hit papers · h-index 47

Impact in

Hepatology top 0.05%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 282
- Hepatitis C virus research 212
- Hepatocellular Carcinoma Treatment and Prognosis 61
- Liver Disease and Transplantation 23
- Liver Diseases and Immunity 12
Epidemiology 259
- Liver Disease Diagnosis and Treatment 215
- Hepatitis B Virus Studies 159

Co-authors: Norio Akuta (251 shared papers)Fumitaka Suzuki (251 shared papers)Masahiro Kobayashi (251 shared papers)Yoshiyuki Suzuki (251 shared papers)Hiromitsu Kumada (251 shared papers)Yasuji Arase (251 shared papers)Hitomi Sezaki (251 shared papers)Satoshi Saitoh (231 shared papers)
Journals: Journal of Medical Virology (52 papers)Hepatology Research (47 papers)Journal of Gastroenterology (33 papers)Oncology (15 papers)Liver International (8 papers)
Partner nations: Japan Taiwan United States

In The Last Decade

Tetsuya Hosaka

315 papers receiving 8.7k citations

Tetsuya Hosaka's Hit Papers

align trajectories log scale

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis 2020 · 586 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 The Lancet. Gastroenterology & hepatology
2012 Hepatology

Peers

Countries citing papers authored by Tetsuya Hosaka

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Hosaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Hosaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Hosaka more than expected).

Fields of papers citing papers by Tetsuya Hosaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Hosaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Hosaka. The network helps show where Tetsuya Hosaka may publish in the future.

Co-authors

The 25 scholars most cited alongside Tetsuya Hosaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tetsuya Hosaka Line = papers co-authored together Tetsuya Hosaka links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 324 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis The Lancet. Gastroenterology & hepatology ·Qing Ye, Biyao Zou, Yee Hui Yeo, Jie Li, Daniel Q. Huang, Yuankai Wu, Hongli Yang, Chuanli Liu, Leslie Y. Kam, Xiang Xuan Eunice Tan, Nicholas Chien, Sam Trinh, Linda Henry, Christopher D Stave, Tetsuya Hosaka, Ramsey Cheung, Mindie H. Nguyen Hit paper breakdown →	2020	586
2	Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection Hepatology ·Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, Yuya Seko, Yusuke Kawamura, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada Hit paper breakdown →	2012	518
3	Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma The American Journal of Gastroenterology ·Yusuke Kawamura, Yasuji Arase, Kenji Ikeda, Yuya Seko, Norihiro Imai, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Yuki Ohmoto, Kazuhisa Amakawa, Hiroshi Tsuji, Hiromitsu Kumada	2011	231
4	Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy Intervirology ·Norio Akuta, Fumitaka Suzuki, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Sachiyo Watahiki, Junko Sato, Marie Matsuda, Mariko Kobayashi, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2005	226
5	Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels Journal of Hepatology ·Norio Akuta, Fumitaka Suzuki, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2006	222
6	Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin† Hepatology ·Norio Akuta, Fumitaka Suzuki, Miharu Hirakawa, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Kazuaki Chayama, Yusuke Nakamura, Hiromitsu Kumada	2010	206
7	Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C† Hepatology ·Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki, Norio Akuta, Masahiro Kobayashi, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Miharu Hirakawa, Kenji Ikeda, Hiromitsu Kumada	2008	204
8	Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale Supportive Care in Cancer ·Toru Okuyama, Tatsuo Akechi, Akira Kugaya, Hitoshi Okamura, Shigeru Imoto, Tomohito Nakano, Ichiro Mikami, Tetsuya Hosaka, Yosuke Uchitomi	2000	174
9	Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C Hepatology ·Yasuji Arase, Mariko Kobayashi, Fumitaka Suzuki, Yoshiyuki Suzuki, Yusuke Kawamura, Norio Akuta, Masahiro Kobayashi, Hitomi Sezaki, Satoshi Saito, Tetsuya Hosaka, Kenji Ikeda, Hiromitsu Kumada, Tetsuro Kobayashi	2012	137
10	Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients Journal of Hepatology ·Atsushi Ono, Fumitaka Suzuki, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitou, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki, Rie Mineta, Hiromitsu Kumada	2012	126
11	Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B The American Journal of Medicine ·Yasuji Arase, Kenji Ikeda, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Masahiro Kobayashi, Norio Akuta, Takashi Someya, Tetsuya Hosaka, Hitomi Sezaki, Mariko Kobayashi, Hiromitsu Kumada	2006	106
12	The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment Journal of Hepatology ·Norio Akuta, Fumitaka Suzuki, Mariko Kobayashi, Akihito Tsubota, Yoshiyuki Suzuki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2003	100
13	Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis Cancer ·Masahiro Kobayashi, Kenji Ikeda, Tetsuya Hosaka, Hitomi Sezaki, Takashi Someya, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Hiromitsu Kumada	2005	99
14	Viral Elimination Reduces Incidence of Malignant Lymphoma in Patients with Hepatitis C The American Journal of Medicine ·Yusuke Kawamura, Kenji Ikeda, Yasuji Arase, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada	2007	96
15	Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis Hepatology ·Norio Akuta, Fumitaka Suzuki, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2007	95
16	Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b Journal of Medical Virology ·Norio Akuta, Fumitaka Suzuki, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Yoshiyuki Suzuki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2007	91
17	Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan Journal of Medical Virology ·Yoshiyuki Suzuki, Mariko Kobayashi, Kenji Ikeda, Fumitaka Suzuki, Yasuji Arfase, Norio Akuta, Tetsuya Hosaka, Satoshi Saitoh, Masahiro Kobayashi, Takashi Someya, Marie Matsuda, Junko Sato, Sachiyo Watabiki, Yuzo Miyakawa, Hiromitsu Kumada	2005	91
18	Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non‐alcoholic fatty liver disease complicated by diabetes mellitus Hepatology Research ·Norio Akuta, Yusuke Kawamura, Chizuru Watanabe, Akihiro Nishimura, Minoru Okubo, Yasumichi Mori, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2018	91
19	Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection Journal of Medical Virology ·Masahiro Kobayashi, Fumitaka Suzuki, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2016	90
20	Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up Journal of Hepatology ·Hiromi Yatsuji, Fumitaka Suzuki, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Sachiyo Watahiki, Satomi Iwasaki, Mariko Kobayashi, Hiromitsu Kumada	2008	90

About Tetsuya Hosaka

Tetsuya Hosaka is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Oncology and Rheumatology, having authored 324 papers that have together received 9.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (215 papers), Hepatitis C virus research (212 papers), Hepatitis B Virus Studies (159 papers), Hepatocellular Carcinoma Treatment and Prognosis (61 papers), HIV/AIDS drug development and treatment (30 papers), Liver Disease and Transplantation (23 papers), Systemic Lupus Erythematosus Research (22 papers) and Liver Diseases and Immunity (12 papers). The work is most often cited by research in Hepatology (7.3k citations), Epidemiology (7.3k citations), Endocrinology, Diabetes and Metabolism (755 citations), Infectious Diseases (667 citations) and Rheumatology (531 citations). Tetsuya Hosaka has collaborated with scholars based in Japan, Taiwan and United States. Frequent co-authors include Norio Akuta, Fumitaka Suzuki, Masahiro Kobayashi, Yoshiyuki Suzuki, Hiromitsu Kumada, Yasuji Arase, Hitomi Sezaki, Satoshi Saitoh, Yusuke Kawamura and Mariko Kobayashi. Their work appears in journals such as Journal of Medical Virology, Hepatology Research, Journal of Gastroenterology, Oncology and Liver International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Tetsuya Hosaka

Impact in

Papers in i

In The Last Decade

Tetsuya Hosaka

Tetsuya Hosaka's Hit Papers

Peers

Countries citing papers authored by Tetsuya Hosaka

Fields of papers citing papers by Tetsuya Hosaka

All Works

About Tetsuya Hosaka

Explore authors with similar magnitude of impact

Papers in